+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3f Enable long-term follow-up study



Clinical performance of a sutureless aortic bioprosthesis: five-year results of the 3f Enable long-term follow-up study



Journal of Thoracic and Cardiovascular Surgery 148(4): 1681-1687



Sutureless valves are designed to facilitate surgical implantation, including less-invasive techniques in aortic valve replacement, by maintaining surgical precision of implantation compared with transcatheter techniques. Long-term clinical experience with sutureless valves is lacking. We report the 5-year follow-up results of an international, prospective, multicenter study evaluating the clinical performance and safety of the 3f Enable valve (Medtronic Inc, Minneapolis, Minn). Between March 2007 and December 2009, 141 patients (54 male; mean age, 76.1±5.7 years) undergoing aortic valve replacement with the 3f Enable valve were enrolled in 10 European sites. The mean follow-up was 2.76 years (range, 2 days to 5.1 years; total, 388.7 patient-years). Echocardiographic valvular hemodynamic and morphologic analyses were performed by an independent core laboratory. The mean systolic gradient was 10.4±4.4 mm Hg at discharge and 7.7±4.1 mm Hg at 5 years. The mean effective orifice area was 1.7±0.5 cm2 at discharge and 1.6±0.2 cm2 at 5 years. Freedom from all-cause and valve-related mortality was 87.6%±2.9% and 96.8%±1.6% at 1 year (113 patients at risk) and 77.0%±7.5% and 93.8%±4.8% at 5 years (24 patients at risk), respectively. Six patients underwent reoperation (4 because of major paravalvular leakage and 2 because of endocarditis). Freedom from reoperation was 95.4%±1.9% at 1 year and 95.4%±6.1% at 5 years. No structural valve deterioration occurred during the follow-up period. The sutureless 3f Enable valve represents a safe and effective treatment for aortic valve stenosis, providing an excellent hemodynamic profile. This study represents the longest follow-up study for a sutureless bioprosthesis. Sutureless valves may become an option for all patients with indicated biological aortic valve replacement.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052125654

Download citation: RISBibTeXText

PMID: 24787699

DOI: 10.1016/j.jtcvs.2014.03.054


Related references

Short-term follow up with the 3f Enable aortic bioprosthesis: clinical and echocardiographic results. Journal of Heart Valve Disease 22(6): 817-823, 2013

First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis. European Journal of Cardio-Thoracic Surgery 33(4): 542-547, 2008

Applications for Enable sutureless aortic bioprosthesis?. Journal of Thoracic and Cardiovascular Surgery 152(2): 637, 2016

Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis. Annals of Thoracic Surgery 87(6): 1914-1917, 2009

Right anterior minithoracotomy aortic valve replacement with a sutureless bioprosthesis: Early outcomes and 1-year follow-up from 2 European centers. Journal of Thoracic and Cardiovascular Surgery 149(4): 1052-1057, 2015

Regression of left ventricular mass after implantation of the sutureless 3f Enable aortic bioprosthesis. Texas Heart Institute Journal 42(2): 117-123, 2015

Long-term clinical and echocardiographic follow-up of the Freestyle stentless aortic bioprosthesis. Circulation 126(11 Suppl 1): S198-S204, 2012

Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis. European Journal of Cardio-Thoracic Surgery 40(3): 749-755, 2012

The 3f Enable sutureless bioprosthesis: Early results, safeguards, and pitfalls. Journal of Thoracic and Cardiovascular Surgery 149(6): 1578-1583, 2015

Long-term results of aortic valve replacement with Edwards Prima Plus stentless bioprosthesis: eleven years' follow up. Journal of Heart Valve Disease 15(5): 691-5; Discussion 695, 2006

Total aortic root replacement using the freestyle aortic bioprosthesis in patients 70 years and older: Long-term clinical and echocardiographic results. 2007

Long-term clinical and echocardiographic follow-up of the freestyle stentless aortic bioprosthesis: the Tel Aviv Medical Center experience. Israel Medical Association Journal 15(9): 470-476, 2013

Comparison of long-term results between Hancock porcine bioprosthesis and Carpentier-Edwards pericardial bioprosthesis in the aortic and the mitral positions. Journal of Artificial Organs 4(3): 226-230, 2001

Aortic valve replacement using the Freedom SOLO stentless bioprosthesis: clinical and haemodynamic performance in 625 patients at medium-term follow-up. European Journal of Cardio-Thoracic Surgery 54(6): 1073-1080, 2018

Long-term performance of the Hancock porcine bioprosthesis in the tricuspid position. A review of forty-five patients with fourteen-year follow-up. Journal of Thoracic and Cardiovascular Surgery 99(5): 838-845, 1990